Beranda › Kanker Kandung Kemih › New York

Uji klinis Kanker Kandung Kemih di New York

41 studi untuk Kanker Kandung Kemih mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
dan 2 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

Memorial Sloan Kettering Cancer Center ( Site 5031), New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07232602

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
dan 3 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07000084

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
dan 1 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06770582

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06833073

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

The New York Hospital Medical Center of Queens, Flushing
NYP/Weill Cornell Medical Center, New York
Stony Brook University Medical Center, Stony Brook

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
dan 3 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

New York Oncology Hematology, Albany
New York Oncology Hematology, Clifton Park
Icahn School of Medicine at Mount Sinai, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07421700

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

MSK Commack, Commack
MSK Westchester, Harrison
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
dan 9 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07206225

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Columbia University Irving Medical Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277413

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

Memorial Sloan Kettering Cancer Center ( Site 0832), New York

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, New York
dan 1 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07218380

A Study of Surgical Techniques During Cystectomy

Memorial Sloan Kettering Suffolk-Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
dan 1 lainnya

Menerima pesertaFase 3

Usia 21 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06703476

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

Roswell Park Comprehensive Cancer Center, Buffalo

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06733363

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Icahn School of Medicine at Mount Sinai, New York
Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07217171

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06644755

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Integrated Medical Professionals, PLLC (Solaris), New York
University of Rochester, Rochester
SUNY Upstate, Syracuse
dan 2 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06567743

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lainnya

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05837767

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
University of Rochester, Department of Urology, Rochester
Associated Medical Professionals of NY, PLLC, Syracuse
dan 1 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

New York University (NYU), New York
Weill Cornell Medicine, New York
Icahn School of Medicine at Mount Sinai, New York
dan 4 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05614739

Measuring Surgical Recovery After Radical Cystectomy

Winthrop University Hospital, Mineola
University of Rochester, Rochester

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT03193970

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
dan 4 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07097142

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Albany Medical College, Albany
Roswell Park Cancer Institute, Buffalo
Mount Sinai Medical Center, New Haven
dan 1 lainnya

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT04752722

A Study of a Side Effects and Resource Navigation Program for People With Cancer

Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
City College of New York (Data Collection AND Specimen Analysis), New York
dan 2 lainnya

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07646847

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 2/3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 2

Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Albany
Research Site, New York

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

MSK Commack, Commack
MSK Wesrchester, Harrison
Memorial Sloan Kattering Cancer Centre- Investigational Drug Service Pharmacy, Long Island City
dan 6 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT04879329

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
dan 7 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04389632

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Albany MED Health System, Albany
Integrated Medical Professionals, New York
Premier Medical Group of the Hudson Valley, P. C., Poughkeepsie

Menerima peserta

Usia 18 hingga 88 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT06394869

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
Memorial Sloan Kettering West Harrison (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT05562791

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

University of Rochester Medical Center, Rochester

Menerima pesertaStudi observasional

Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT03193541

Blue Light Cystoscopy With Cysview® Registry

NYU Langone's Perlmutter Cancer Center, New York

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Des 2025 · NCT02660645

Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion

Mount Sinai Hospital, New York

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06689176

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
dan 2 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.